In Ontario, Canada, a study (21) found that population-wide infection control measures to halt SARS-CoV-2 spread in March 2020 significantly reduced MOGAD cases among children, while MS and AQP4-NMOSD rates remained unchanged. The gene discussed is AQP4; the disease is myeloid sarcoma.